Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus

Gynecologic Oncology

Volumn 94, Issue 3, 2004, Pages 774-778

  Toyoshima, Masafumi ^a   Akahira, Jun Ichi ^a   Matsunaga, Gen ^b   Niikura, Hitoshi ^a   Ito, Kiyoshi ^a   Yaegashi, Nobuo ^a   Tase, Toru ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Miyagi Cancer Center   (Japan)

Author keywords

Carboplatin; Carcinosarcoma; Chemotherapy; Malignant mixed mullerian tumor; Paclitaxel; Uterus

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IFOSFAMIDE; PACLITAXEL; RANITIDINE; VINCRISTINE;

ADULT; ADVANCED CANCER; ALOPECIA; ANEMIA; AREA UNDER THE CURVE; BLOOD TOXICITY; BLOOD TRANSFUSION; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOSARCOMA; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; DISEASE COURSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; LEUKOPENIA; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; UTERUS CARCINOMA; UTERUS SARCOMA;

EID: 4444312652     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.05.048     Document Type: Article

References (25)

1. Major F.J., Blessing J.A., Silverberg S.G., Morrow C.P., Creasman W.T., Currie J.L., et al. Prognostic factors in early-stage uterine sarcoma: a gynecologic oncology group study. Cancer. 71:1993;1702-1709
2. Le T. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population. Eur. J. Surg. Oncol. 27:2001;282-285
3. Chi D.S., Mychalczak B., Saigo P.E., Rescigno J., Brown C.L. The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol. Oncol. 65:1997;493-498
4. Omura G.A., Major F.J., Blessing J.A., Sedlacek T.V., Thigpen J.T., Creasman W.T., et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer. 52:1983;626-632
5. Muss H.B., Bundy B., DiSaia P.J., Homesley H.D., Fowler W.C. Jr., Creasman W., et al. Treatment of recurrent or advanced uterine sarcoma: a randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group). Cancer. 55:1985;1648-1653
6. Sutton G.P., Blessing J.A., Rosenshein N., Photopulos G., DiSaia P.J. Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus: a gynecologic oncology group study. Am. J. Obstet. Gynecol. 161:1989;309-312
7. Sutton G., Brunetto V.L., Kilgore L., Soper J.T., McGehee R., Olt G., et al. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol. Oncol. 79:2000;147-153
8. Thigpen J.T., Blessing J.A., Beecham J., Homesley H., Yordan E. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a gynecologic oncology group study. J. Clin. Oncol. 9:1991;1962-1966
9. Curtin J.P., Blessing J.A., Soper J.T., DeGeest K. Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol. Oncol. 83:2001;268-270
10. van Rijswijk R.E.N., Vermorken J.B., Reed N., Favalli G., Mendiola C., Zanaboni F., et al. Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European organization for research and treatment of cancer gynaecological cancer group (EORTC 55923). Eur. J. Cancer. 39:2003;481-487
11. Iwasa Y., Haga H., Konishi I., Kobashi Y., Higuchi K., Katsuyama E., et al. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients. Cancer. 82:1998;512-519
12. Szukala S.A., Marks J.R., Burchette J.L., Elbendary A.A., Krigman H.R. Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases. Int. J. Gynecol. Cancer. 9:1999;131-136
13. McCluggage W.G. Uterine carcinosarcomas (malignant mixed mullerian tumors) are metaplastic carcinomas. Int. J. Gynecol. Cancer. 12:2002;687-690
14. Holloway R.W. Treatment options for endometrial cancer: experience with topotecan. Gynecol. Oncol. 90:2003;S28-S33
15. Ball H.G., Blessing J.A., Lentz S.S., Mutch D.G. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a gynecologic oncology group study. Gynecol. Oncol. 62:1996;278-281
16. Price F.V., Edwards R.P., Kelly J.L., Kunschner A.J., Hart L.A. A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report. Semin. Oncol. 24:1997;s15-78-s15-82
17. Vasuratna A., Kudelka A.P., Edwards C.L., Wootipoom V., Verschraegen C.F., Charnsangavej C., et al. Prolonged remission of endometrial cancer with paclitaxel and carboplatin. AntiCancer Drugs. 9:1998;283-285
18. Markman M., Kennedy A., Webster K., Kulp B., Peterson G., Belinson J. Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer. Gynecol. Oncol. 73:1999;422-423
19. Szlosarek P.W., Lofts F.J., Pettengell R., Carter P., Young M., Harmer C. Effective treatment of a patients with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel. AntiCancer Drugs. 11:2000;275-278
20. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J. Natl. Cancer Inst. 92:2000;205-216
21. National Cancer Institute (NCI) databases (http://www.cancer.gov/ clinicaltrials).
22. National Cancer Institute - Common Toxicity Criteria Version 2.0, Jan. 30, 1998. (http://ctep.cancer.gov/reporting/ctc.html).
23. Piver M.S., DeEulis T.G., Lele S.B., Barlow J.J. Cyclophosphamide, vincristine, adriamycin, and dimethyltriazenoimidazole carboxamide (CYVADIC) for sarcomas of the female genital tract. Gynecol. Oncol. 14:1982;319-323
24. Hannigan E.V., Freedman R.S., Elder K.W., Rutledge F.N. Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide. Gynecol. Oncol. 15:1983;224-229
25. Currie J.L., Blessing J.A., McGehee R., Soper J.T., Berman M. Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a gynecologic oncology group study. Gynecol. Oncol. 61:1996;94-96